NSEAnalysts/Institutional Investor Meet/Con. Call Updates6d ago · 15 Jul 2026, 07:25 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Anthem Biosciences Limited · ANTHEM

✦ AI SummaryResults

Anthem Biosciences Limited has scheduled an earnings conference call to discuss its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Anthem Biosciences Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

COMPLIANCE_ABL1_15072026192457_InvestorCallIntimationQ1Signed.pdf

pdf

Download →
View document text
Date: July 15, 2026 BSE Limited, National Stock Exchange of India Limited 20th Floor, P.J. Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400001. Bandra Kurla Complex, BSE Scrip Code: 544449 Bandra (E), Mumbai – 400 051 NSE Scrip Symbol: ANTHEM Subject: Intimation of Schedule of Earnings Conference Call under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Ma’am Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an Earnings Conference Call to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026, is scheduled on Wednesday, July 22, 2026 at 11:30 AM IST. The details pertaining to the said call are enclosed herewith and the same will also be available on the Company’s website at https://anthembio.com/ We request you to kindly take the same on record. Thanking you, Yours truly, For Anthem Biosciences Limited (Formerly known as Anthem Biosciences Private Limited) Divya Prasad Company Secretary & Compliance Officer Membership No: A41438 OPTION 1 | Diamond Pass Pre-registration link: CLICK HERE The Management of OPTION 2 | Dial-in through Operator Assistance Anthem Biosciences Limited invites you to the ACCESS NUMBERS Q1 FY27 Earnings +91 22 6280 1102 Universal Access Numbers Conference Call +91 22 7115 8003 The numbers listed above are universally accessible from all networks and all countries. To discuss the performance for the quarter ended June 30, 2026 INTERNATIONAL TOLL FREE NUMBERS USA 186674 62133 DAY / DATE TIME Wednesday, 22nd July, 2026 11:30 am IST UK 080810 11573 Hong Kong 80096 4448 Singapore 80010 12045 MA N A G E ME N T PA R T I C I PAN T S Mr. Ajay Bhardwaj Mr. Gawir Baig Managing Director & CEO Chief Financial Officer Participants are requested to dial-in 5 minutes in advance For more information: Adfactors PR (Investor Relations) Forum Goshar: +91 7045646599 | Email: anthem@adfactorspr.com